Fibroblast Activation Protein: Differential Expression and Serine Protease Activity in Reactive Stromal Fibroblasts of Melanocytic Skin Tumors  Margit.

Slides:



Advertisements
Similar presentations
Nan-Hyung Kim, Ai-Young Lee  Journal of Investigative Dermatology 
Advertisements

Mihaela Skobe, Michael Detmar 
Alvin Y. Liu, Martine P. Roudier, Lawrence D. True 
Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel- Associated Mural Cells  Sven Christian, Renate Winkler, Iris Helfrich,
Stefanie Krenzer, Heike Peterziel, Cornelia Mauch, Sachiko I
Mihaela Skobe, Michael Detmar 
Expression of Purinergic Receptors in Non-melanoma Skin Cancers and Their Functional Roles in A431 Cells  Aina V.H. Greig, Geoffrey Burnstock  Journal.
Functional Melanocytes Are Readily Reprogrammable from Multilineage-Differentiating Stress-Enduring (Muse) Cells, Distinct Stem Cells in Human Fibroblasts 
Basics of Immunohistochemistry
Gianni Gerlini, Hans Peter Hefti, Martin Kleinhans, Brian J
Epstein–Barr Virus Infection Induces Aberrant TLR Activation Pathway and Fibroblast– Myofibroblast Conversion in Scleroderma  Antonella Farina, Mara Cirone,
Dual Mode Reflectance and Fluorescence Confocal Laser Scanning Microscopy for In Vivo Imaging Melanoma Progression in Murine Skin  Yanyun Li, Salvador.
The SCF/KIT Pathway Plays a Critical Role in the Control of Normal Human Melanocyte Homeostasis  James M. Grichnik, James A. Burch, James Burchette, Christopher.
Zhuo Li, Dieter Metze, Dorothea Nashan, Carsten Müller-Tidow, Hubert L
Epidermal Growth Factor Facilitates Melanoma Lymph Node Metastasis by Influencing Tumor Lymphangiogenesis  Andreas Bracher, Ana Soler Cardona, Stefanie.
Basement Membrane Zone Remodeling During Appendageal Development in Human Fetal Skin. The Absence of Type VII Collagen is Associated with Gelatinase-A.
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Coexpression of Integrin αvβ3 and Matrix Metalloproteinase-2 (MMP-2) Coincides with MMP-2 Activation: Correlation with Melanoma Progression  Uta B. Hofmann,
Adam Giangreco, Stephen J
In Vivo Detection of Small Subsurface Melanomas in Athymic Mice Using Noninvasive Fiber Optic Confocal Imaging  Peter Anikijenko, Liem T. Vo, Elise R.
Fibronectin-Containing Extracellular Vesicles Protect Melanocytes against Ultraviolet Radiation-Induced Cytotoxicity  Bum-Ho Bin, Dae-Kyum Kim, Nan-Hyung.
Jasper G. van den Boorn, Debby Konijnenberg, Trees A. M. Dellemijn, J
Pro-opiomelanocortin-Related Peptides, Prohormone Convertases 1 and 2 and the Regulatory Peptide 7B2 are Present in Melanosomes of Human Melanocytes 
Loss of EPC-1/PEDF Expression During Skin Aging In Vivo
Marie-Thérèse Leccia  Journal of Investigative Dermatology 
Cross-Linking of SPINK6 by Transglutaminases Protects from Epidermal Proteases  Jan Fischer, Yulia Koblyakova, Ties Latendorf, Zhihong Wu, Ulf Meyer-Hoffert 
Phenotypic and Functional Outcome of Human Monocytes or Monocyte-Derived Dendritic Cells in a Dermal Equivalent  G. Guironnet, C. Dezutter-Dambuyant,
Increased Expression of the Orphan Nuclear Receptor NURR1 in Psoriasis and Modulation following TNF-α Inhibition  Marina O'Kane, Trevor Markham, Alice.
Ultraviolet Light (UVB and UVA) Induces the Damage-Responsive Transcription Factor CHOP/gadd153 in Murine and Human Epidermis: Evidence for a Mechanism.
Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9  Joanna Nikitorowicz-Buniak,
Fatty Acid Transport Protein 1 Can Compensate for Fatty Acid Transport Protein 4 in the Developing Mouse Epidermis  Meei-Hua Lin, Jeffrey H. Miner  Journal.
Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9  Joanna Nikitorowicz-Buniak,
Activin A Is Anti-Lymphangiogenic in a Melanoma Mouse Model
Activation of Epidermal Growth Factor Receptor/ERK Signaling Correlates with Suppressed Differentiation in Malignant Acanthosis Nigricans  Ingo Haase,
Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi
Light and Electron Microscopic Demonstration of the p75 Nerve Growth Factor Receptor in Normal Human Cutaneous Nerve Fibers: New Vistas  Yong Liang, Olle.
Elise S. Bales, Cheryl Dietrich, Debdutta Bandyopadhyay, Denise J
Alexandra Charruyer, Lauren R. Strachan, Lili Yue, Alexandra S
Changing Pattern of Deiminated Proteins in Developing Human Epidermis
Histidine Decarboxylase Expression in Human Melanoma
Presence of Epstein–Barr Virus in Langerhans Cells of CTCL Lesions
The Role of Oxidative DNA Damage in Human Arsenic Carcinogenesis: Detection of 8- Hydroxy-2′-Deoxyguanosine in Arsenic-Related Bowen's Disease  Miho Matsui,
Mary Eid, Jannett Nguyen, Isaac Brownell 
Engineered Human Skin Substitutes Undergo Large-Scale Genomic Reprogramming and Normal Skin-Like Maturation after Transplantation to Athymic Mice  Jennifer.
Expression of T-Cadherin in Basal Keratinocytes of Skin
Transient Expression of Ephrin B2 in Perinatal Skin Is Required for Maintenance of Keratinocyte Homeostasis  Gyohei Egawa, Masatake Osawa, Akiyoshi Uemura,
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Trangenic Misexpression of the Differentiation-Specific Desmocollin Isoform 1 in Basal Keratinocytes  Frank Henkler, Molly Strom, Kathleen Mathers, Hayley.
Versican, a Major Hyaluronan-Binding Component in the Dermis, Loses its Hyaluronan- Binding Ability in Solar Elastosis  Keiko Hasegawa, Masahiko Yoneda,
Sharon F. Suchy, Robert L. Nussbaum 
Selective Loss of Wild-Type p16INK4a Expression in Human Nevi
Molecular Consequences of Deletion of the Cytoplasmic Domain of Bullous Pemphigoid 180 in a Patient with Predominant Features of Epidermolysis Bullosa.
Keratinocytes Express the CD146 (Muc18/S-Endo) Antigen in Tissue Culture and During Inflammatory Skin Diseases1  Wolfgang Weninger, Michael Rendl, Michael.
Chromosomally Clonal T Cells in the Skin, Blood, or Lymph Nodes of Two Sezary Syndrome Patients Express CD45RA, CD45RO, CDw150, and Interleukin-4, but.
Role of Cytotoxic T Cells in Chronic Alopecia Areata
Normal Wound Healing in Mice Deficient for Fibulin-5, an Elastin Binding Protein Essential for Dermal Elastic Fiber Assembly  Qian Zheng, Jiwon Choi,
Enhanced Expression of Human Metalloelastase (MMP-12) in Cutaneous Granulomas and Macrophage Migration  Maarit Vaalamo, Arja-Leena Kariniemi, Ulpu Saarialho-Kere 
Organization of Stem Cells and Their Progeny in Human Epidermis
Overexpression of the Oncofetal Fn Variant Containing the EDA Splice-in Segment in the Dermal–Epidermal Junction of Psoriatic Uninvolved Skin  Kathleen.
Anna Flammiger, Robert Besch, Anthony L. Cook, Tanja Maier, Richard A
Nan-Hyung Kim, Ai-Young Lee  Journal of Investigative Dermatology 
Kei Wada, Chihaya Maesawa, Toshihide Akasaka, Tomoyuki Masuda 
Regine Keller-Melchior, Rodney Schmidt, Michael Piepkorn 
Mads Hald Andersen, Sine Reker, Jürgen C. Becker, Per thor Straten 
Madhuri Bhandaru, Magdalena Martinka, Gang Li, Anand Rotte 
Solar-Simulated Ultraviolet Radiation-Induced Upregulation of the Melanocortin-1 Receptor, Proopiomelanocortin, and α-Melanocyte-Stimulating Hormone in.
Activation of Keratinocyte Protein Kinase Cζ in Psoriasis Plaques
The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor- Inhibiting Doses  Bernhard Lange-Asschenfeldt, Paula Velasco, Michael Streit,
Expression of Ligands to NKp46 in Benign and Malignant Melanocytes
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

Fibroblast Activation Protein: Differential Expression and Serine Protease Activity in Reactive Stromal Fibroblasts of Melanocytic Skin Tumors  Margit A. Huber, Roland D. Schubert, Ralf U. Peter  Journal of Investigative Dermatology  Volume 120, Issue 2, Pages 182-188 (February 2003) DOI: 10.1046/j.1523-1747.2003.12035.x Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Immunohistochemical detection of FAP in melanocytic nevi with monoclonal antibody F19. Melanocytic nevi (A–F) were stained either with hematoxylin-eosin (A, C, E), or with monoclonal antibody F19 to detect FAP expression (B, D, F). FAP immunoreactivity was seen in the reactive stromal fibroblasts surrounding the nevi (arrows; B, D, F), but also on subsets of melanocytic cells at the dermo-epidermal junction (arrowheads; D, F) in compound nevi (C, E). Scale bar: 50 μm. Journal of Investigative Dermatology 2003 120, 182-188DOI: (10.1046/j.1523-1747.2003.12035.x) Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Immunohistochemical detection of FAP in primary melanomas with monoclonal antibody F19. Primary melanomas (A–D) were stained either with hematoxylin-eosin (A), or with monoclonal antibody F19 to detect FAP expression (B–D). FAP immunoreactivity was detected in stromal fibroblasts around the melanoma cell clusters (arrows). Scale bar: 50 μm. Journal of Investigative Dermatology 2003 120, 182-188DOI: (10.1046/j.1523-1747.2003.12035.x) Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Immunohistochemical detection of FAP and Endoglyx-1 in metastatic melanomas. Melanoma metastases (A–H) were stained with hematoxylin-eosin (A), with monoclonal antibody F19 (C, E, G), or with monoclonal antibody H572 to detect the endothelial-specific Endoglyx-1 protein (B, D, F, H). Immunostainings of adjacent serial sections (C/D, E/F, G/H) demonstrate that conventional tumor blood vessels (bv) are Endoglyx-1 positive (D, F, H) and FAP negative (C, E, G). Note the networks of FAP-positive (Endoglyx-1-negative) loops and channels observed in a subset of metastatic melanomas (C, E, G). Scale bar: 50 μm. Journal of Investigative Dermatology 2003 120, 182-188DOI: (10.1046/j.1523-1747.2003.12035.x) Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 FAP expression on patterned structures does not overlap with endothelial and melanoma cell markers. Sections from metastatic melanoma lesions were examined under a confocal microscope for colocalization of FAP with endothelial markers. Double stainings were carried out with monoclonal antibody F19 detected by Alexa-488-conjugated secondary antibody (green fluorescence, A–C) and with monoclonal antibody H572 detected by Alexa-546-conjugated secondary antibody (red fluorescence, A–C) staining endothelial cells of blood vessels (bv). Monoclonal antibody F19 detected with Cy2-conjugated secondary antibody (green fluorescence, D–F) and anti-gp100/HMB45 detected with Cy3-conjugated antibody (red fluorescence, D–F) were used for colocalization of FAP and the melanoma marker gp100 staining melanoma cells (mc). Color overlay analysis demonstrates no colocalization of FAP with Endoglyx-1 (A–C) or with gp100 (D–F). Scale bar: 50 μm. Journal of Investigative Dermatology 2003 120, 182-188DOI: (10.1046/j.1523-1747.2003.12035.x) Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Dipeptidyl peptidase activity of FAP measured in extracts of human melanoma metastases (blue symbols), melanocytic nevi (red symbols), and matched normal skin (open symbols). Melanoma samples included three specimens from one individual (circles) and two specimens from another patient (triangles); all other samples in this figure (squares) were from different patients. FAP activity was measured using concanavalin-A-enriched membrane fractions, followed by binding to F19-coated plates and incubation with Ala-Pro-AFC as substrate. The bars and respective numbers represent the mean of each category. The differences between the means for melanoma metastases and melanocytic nevi versus normal skin, respectively, are significant at p<10–4 by Student's t test. Journal of Investigative Dermatology 2003 120, 182-188DOI: (10.1046/j.1523-1747.2003.12035.x) Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions